Skip to main content
Equibles

CAPITAL INTERNATIONAL LTD /CA/

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1065350 LOS ANGELES, CA
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,520,674
-$1,994,956 QoQ
Shares Held
13,665
+0.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#320
of 1,329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL INTERNATIONAL LTD /CA/ holds $127,577,689 across 7 Biotechnology names. REGN ranks #5 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 97,334 $48,348,717
2 RPRX
Royalty Pharma plc
 579,801 $32,509,442
3 ONC
BeOne Medicines Ltd.
 77,161 $21,988,570
4 ALNY
Alnylam Pharmaceuticals, Inc.
 29,166 $8,779,840
5 REGN
Regeneron Pharmaceuticals, Inc.
This page 		13,665 $8,520,674
6 ASND
Ascendis Pharma A/S
 16,394 $4,372,607
7 CRSP
CRISPR Therapeutics AG
 56,066 $3,057,839

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,520,674 13,665
2026-03-31 $10,515,630 13,610
2025-12-31 $10,505,150 13,610
2025-09-30 $15,694,080 27,912
2025-06-30 $17,803,275 33,911
2025-03-31 $27,368,292 43,152
2024-12-31 $29,182,735 40,968
2024-09-30 $37,603,906 35,771
2024-06-30 $36,548,517 34,774
2024-03-31 $29,868,952 31,033
2023-12-31 $21,101,795 24,026
2023-09-30 $19,390,583 23,562
2023-06-30 $20,383,542 28,368
2023-03-31 $25,707,589 31,287
2022-12-31 $23,009,037 31,891
2022-09-30 $22,380,697 32,489
2022-06-30 $17,168,188 29,043
2022-03-31 $19,315,503 27,656
2021-12-31 $15,462,767 24,485
2021-09-30 $14,754,893 24,381
2021-06-30 $13,778,623 24,669
2021-03-31 $12,210,797 25,808
2020-12-31 $13,731,918 28,424
2020-09-30 $15,732,616 28,105
2020-06-30 $14,532,292 23,302
2020-03-31 $11,507,042 23,566